| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHL2101005 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2021-04-07 | view | ||||
| JXHL2101006 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2021-04-07 | view | ||||
| JXHL2000103 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-05-16 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2020-05-15 | view |
| JXHL2000102 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-05-16 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2020-05-15 | view |
| JYHB1901107 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs | Supplementary Application | 2019-09-16 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2019-09-13 | view |
| JYHB1901104 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs | Supplementary Application | 2019-09-16 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2019-09-13 | view |
| JXHL1900110 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2019-05-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2019-05-17 | view |
| JXHL1900109 | Talazoparib胶囊 | talazoparib tosylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2019-05-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2019-05-17 | view |